MECHANISMS OF UNPREDICTABLE ADVERSE DRUG-REACTIONS

被引:45
作者
RIEDER, MJ
机构
[1] Division of Clinical Pharmacology, Child Health Research Institute, J.R. Roberts Research Institute, Departments of Paediatrics, Pharmacology and Toxicology and Medicine, University of Western Ontario, London, Ontario
[2] Division of Clinical Pharmacology, Department of Paediatrics, Children’S Hospital of Western Ontario, London, Ontario, N6C 2V5
关键词
D O I
10.2165/00002018-199411030-00005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Adverse drug reactions are common problems associated with therapy, and are major sources of morbidity and mortality. There are numerous types of drug reactions, including predictable drug reactions such as side effects, toxicity, drug interactions and secondary effects that can be anticipated when planning therapy. There are also a number of unpredicted adverse effects, which are unexpected consequences of therapy. The least severe unpredicted adverse drug reaction is intolerance, which appears to be an exaggeration of pharmacological or toxic effects of the drug among vulnerable subsets of patients. Some of the most severe and life-threatening adverse drug reactions are allergic. These adverse effects can be mediated by a number of mechanisms, including the development of drug-specific IgE, serum-sickness-like reactions in response to drug-antibody complexes, direct release of inflammatory mediators, or involvement of the immune system by mechanisms that are poorly understood. Idiosyncratic adverse drug reactions are a heterogeneous group of adverse effects that are not predictable from the pharmacological actions of the drug. Many of these reactions occur as a consequence of pharmacogenetic variations in drug bioactivation and drug or metabolite detoxification or clearance. The physician must be vigilant for the possibility of unpredictable adverse drug reactions during or after therapy. Research currently underway may afford the opportunity to predict, and hopefully prevent, some of these adverse reactions in the future.
引用
收藏
页码:196 / 212
页数:17
相关论文
共 117 条
[61]  
Carrington D.M., Earl H.S., Sullivan T.J., Studies of human IgE to a sulfonamide determinant, J Allergy Clin Immunol, 74, (1987)
[62]  
Lawley T.J., Bielory L., Gascon P., Et al., A prospective clinical and immunologic analysis of patients with serum sickness, N Engl J Med, 311, (1984)
[63]  
Bielory L., Gascon P., Lawley T.J., Et al., Human serum sickness: a prospective analysis of 35 patients treated with equine antierythrocyte globulin for bone marrow factors, Medicine, 67, pp. 40-57, (1988)
[64]  
Alanis W., Weinstein A.J., Adverse reactions associated with the use of oral penicillins and cephalosporins, Med Clin North Am, 67, (1983)
[65]  
Lovell S.J., Reid W.D., Serum sickness with cefaclor, Can Med Assoc J, 126, (1982)
[66]  
Lin R.Y., Serum sickness syndrome, Am Fam Physician, 157, (1986)
[67]  
Mackowiak P.H., LeMaistre C.F., Drug fever: a critical appraisal of conventional concepts, Ann Intern Med, 106, (1987)
[68]  
Siegel M., Lee S.L., Peress N.S., The epidemiology of druginduced systemic lupus erythematosus, Arthritis Rheum, 10, (1967)
[69]  
Gilliland B.C., Drug-induced autoimmune and hematologic disorders, Immunol Allergy Clin North Am, 11, (1991)
[70]  
Uetrecht J.P., Mechanism of drug-induced lupus, Chem Res Toxicol, 1, (1988)